doi: 10.1111/j.1365-2125.2009.03522.x
Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
Planning your nutrition for travel days and your destination can prevent uncomfortable gastrointestinal episodes and keep your energy stable
Dosing Example: A 1mg dose would require a draw of 0.4 mL (or 40 units)
Eloralintide is a medication in testing from Eli Lilly that targets amylin
5.2 Dual GIPR/GLP-1r agonists Tirzepatide, a dual GIP and GLP-1 receptor agonist, is a new therapeutic class with enhanced efficacy in patients with CRHM syndrome